A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets
Part of paid clinical trials in Daytona Beach, Florida.
- Sponsor
- Amgen
- Study ID
- NCT05327491
- Phase
- PHASE1
- Status
- Completed
Conditions
- Healthy Participants
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Sotorasib — DRUGOral Tablet
Study Details
The primary objective of the study is to compare the pharmacokinetics (PK) of sotorasib administered orally as 1 tablet under fasted conditions to sotorasib administered orally as 2 tablets under fasted conditions.
Key Dates
- Start date
- Mar 21, 2022
- Status verified
- Mar 2023
- Primary completion
- Jul 17, 2022
- Completion
- Jul 17, 2022
Study Design
- Enrollment
- 146 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment Sequence ABCParticipants will be administered sotorasib orally in the following order: Period 1 - as 1 tablet (test 1) Period 2 - as 2 tablets (reference) Period 3 - as 1 tablet (test 2)
- Experimental: Treatment Sequence BACParticipants will be administered sotorasib orally in the following order: Period 1 - as 2 tablets (reference) Period 2 - as 1 tablet (test 1) Period 3 - as 1 tablet (test 2)
Primary Outcome Measure
Period 1 and 2: Maximum Observed Plasma Concentration (Cmax) of Sotorasib [ Time Frame: Predose, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 10, 12, 24, 36, and 48 hours postdose following administration of sotorasib on the 1st day of each period (Days 1 and 4) ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Labcorp Clinical Research Unit - Daytona Beach | Daytona Beach | Florida | 32117-5116 | - |
| Miami Research Associates LLC - Main Campus / Late Phase | South Miami | Florida | 33143-5026 | - |
| Labcorp Clinical Research Unit - Dallas | Dallas | Texas | 75247-4989 | - |
| Labcorp Clinical Research Unit - Madison | Madison | Wisconsin | 53704-2526 | - |
Find similar trials in Daytona Beach, FL
Related Studies
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsPHASE1 · Recruiting · Pfizer · Anaheim, California
- A Study of Oral E1018 in Healthy Adult ParticipantsPHASE1 · Recruiting · Eisai Inc. · Austin, Texas
- A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating WomenPHASE1 · Recruiting · UCB Biopharma SRL · San Antonio, Texas
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With DyslipidemiaPHASE1 · Recruiting · AstraZeneca · Glendale, California